Quadrant Capital Group LLC Codexis, Inc. Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
60.6MCall Options Held
68.5KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.84MShares$27.1 Million8.29% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$24.9 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$20.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$13.7 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$9.21 Million1.53% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $201M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...